Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Prestige Consumer Healthcare (PBH) EBITDA: 2009-2025

Historic EBITDA for Prestige Consumer Healthcare (PBH) over the last 17 years, with Mar 2025 value amounting to $211.4 million.

  • Prestige Consumer Healthcare's EBITDA fell 27.56% to $42.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $195.8 million, marking a year-over-year decrease of 9.11%. This contributed to the annual value of $211.4 million for FY2025, which is 2.44% up from last year.
  • Prestige Consumer Healthcare's EBITDA amounted to $211.4 million in FY2025, which was up 2.44% from $206.4 million recorded in FY2024.
  • Over the past 5 years, Prestige Consumer Healthcare's EBITDA peaked at $211.4 million during FY2025, and registered a low of -$94.8 million during FY2023.
  • Moreover, its 3-year median value for EBITDA was $206.4 million (2024), whereas its average is $107.7 million.
  • Its EBITDA has fluctuated over the past 5 years, first crashed by 146.00% in 2023, then soared by 317.64% in 2024.
  • Over the past 5 years, Prestige Consumer Healthcare's EBITDA (Yearly) stood at $189.0 million in 2021, then rose by 9.05% to $206.2 million in 2022, then crashed by 146.00% to -$94.8 million in 2023, then spiked by 317.64% to $206.4 million in 2024, then grew by 2.44% to $211.4 million in 2025.